These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 27766882

  • 1. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
    Thakral NK, Behme RJ, Aburub A, Peterson JA, Woods TA, Diseroad BA, Suryanarayanan R, Stephenson GA.
    Mol Pharm; 2016 Dec 05; 13(12):4141-4151. PubMed ID: 27766882
    [Abstract] [Full Text] [Related]

  • 2. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.
    Merritt JM, Viswanath SK, Stephenson GA.
    Pharm Res; 2013 Jan 05; 30(1):203-17. PubMed ID: 22918819
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Crystalline solid dispersion-a strategy to slowdown salt disproportionation in solid state formulations during storage and wet granulation.
    Nie H, Xu W, Taylor LS, Marsac PJ, Byrn SR.
    Int J Pharm; 2017 Jan 30; 517(1-2):203-215. PubMed ID: 27979765
    [Abstract] [Full Text] [Related]

  • 7. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
    Cavanagh KL, Maheshwari C, Rodríguez-Hornedo N.
    J Pharm Sci; 2018 Jan 30; 107(1):113-120. PubMed ID: 29097226
    [Abstract] [Full Text] [Related]

  • 8. Disproportionation of Pharmaceutical Salts: pHmax and Phase-Solubility/pH Variance.
    Avdeef A.
    Mol Pharm; 2021 Jul 05; 18(7):2724-2743. PubMed ID: 34142831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A.
    Pharm Res; 2006 Aug 05; 23(8):1888-97. PubMed ID: 16832611
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stability of pharmaceutical salts in solid oral dosage forms.
    Nie H, Byrn SR, Zhou QT.
    Drug Dev Ind Pharm; 2017 Aug 05; 43(8):1215-1228. PubMed ID: 28276282
    [Abstract] [Full Text] [Related]

  • 17. Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt.
    Patel MA, Luthra S, Shamblin SL, Arora KK, Krzyzaniak JF, Taylor LS.
    Int J Pharm; 2018 Jul 30; 546(1-2):226-234. PubMed ID: 29772284
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantifying Disproportionation in Pharmaceutical Formulations with 35Cl Solid-State NMR.
    Hirsh DA, Su Y, Nie H, Xu W, Stueber D, Variankaval N, Schurko RW.
    Mol Pharm; 2018 Sep 04; 15(9):4038-4048. PubMed ID: 30016112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.